TMAO inhibited bile acid synthesis through activation of small heterodimer partner (SHP) and farnesoid X receptor (FXR) pathway and downregulation of Cyp7a1 expression, suggesting that TMAO-induced atherosclerosis progression is correlated with disturbances in lipid and bile acid metabolism [124]. This evidence concerns the gene NR1H4 and atherosclerosis.